glp-1 agonists drugs Market Overview: and the Obesity Market | Blog GLP-1 Receptor Agonists | New
Description
NPY is an orexigenic peptide, while AgRP acts as an antagonist of the melanocortin receptors
Invalid Email Address Thank You for Subscribing
We incorporate these findings into a broader model of GLP1 medication response, and demonstrate the ability to stratify patients by efficacy and side effect risk
Neuroreport 15 , 655658 (2004)
Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F
